New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval
source: shutterstock.com

New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval

According to a press release from the US Food and Drug Administration (FDA), on March 24, 2023, the agency issued a new draft guidance titled Clinical Trial Considerations to Support Accelerated…

Continue Reading New Guidance from the FDA Intends to Improve Cancer Clinical Trials for Accelerated Approval
Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis
source: shutterstock.com

Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis

  People living with bronchiectasis, a chronic condition characterized by damaged airways, experience progressive lung damage and inflammation. This can lead to a multitude of consequences, including a reduction in…

Continue Reading Enrollment Complete for Phase 3 Study Evaluating Brensocatib for Non-CF Bronchiectasis
Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research
source: shutterstock.com

Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research

Rare Community Profiles     Rare Community Profiles is a new Patient Worthy article series of long-form interviews featuring various stakeholders in the rare disease community, such as patients, their…

Continue Reading Rare Community Profiles: Their Daughter’s Rare Disease Empowered the Traller Family to Advocate for ASPS Awareness and Research